Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course/Experiment 4/Signature 1

From BugSigDB
Reviewed Marked as Reviewed by ChiomaBlessing on 2024-10-21

Curated date: 2024/10/04

Curator: MyleeeA

Revision editor(s): MyleeeA

Source: Figure 4

Description: Differential abundance of taxa in the Multiple Sclerosis and control subjects from Whole Genome Sequencing (WGS) analysis as determined by LDA effect size (LEfSe).

Abundance in Group 1: increased abundance in Multiple Sclerosis (MS)

NCBI Quality ControlLinks
Adlercreutzia equolifaciens
Alistipes onderdonkii
Anaerofustis stercorihominis
Anaerotruncus colihominis
Blautia producta
Clostridium sp. KLE 1755
Dialister invisus
Eggerthella lenta
Enterocloster asparagiformis
Enterocloster bolteae
Enterocloster citroniae
Enterocloster clostridioformis
Erysipelotrichaceae bacterium 2_2_44A
Erysipelotrichaceae bacterium 6_1_45
Escherichia coli
Eubacterium sp. 3_1_31
Gardnerella vaginalis
Gordonibacter pamelaeae
Hoylesella timonensis
Hungatella hathewayi
Intestinibacter bartlettii
Lachnospiraceae bacterium 3_1_57FAA_CT1
Lachnospiraceae bacterium 5_1_57FAA
Lactococcus lactis
Mediterraneibacter gnavus
Peptostreptococcus anaerobius
Porphyromonas asaccharolytica
Porphyromonas uenonis
Prevotella bivia
Prevotella disiens
Ruminococcus sp. 5_1_39BFAA
Streptococcus mutans
Subdoligranulum sp. 4_3_54A2FAA
Thomasclavelia ramosa
[Clostridium] innocuum
[Clostridium] leptum
[Clostridium] methylpentosum
[Clostridium] nexile
[Clostridium] symbiosum

Revision editor(s): MyleeeA